The Latest Breaking News from Science

In a mouse study published Thursday in the journal Science, researchers found that inflammation lingered in mice that had been fed a high-fat diet after the rodents shed the ounces.

Researchers find that up to half of glaciers will disappear by the end of the century, but even more could be lost under higher global warming scenarios.

These insects seem to eat pretty much anything, and as the climate warms their numbers are only increasing – Australia should be a warning to the rest of the world, writes Frances Vinall

Now you see them, now you don’t. Some frogs found in South and Central America have the rare ability to turn on and off their nearly transparent appearance, researchers report Thursday in the journal Science. During the day, these nocturnal frogs sleep by hanging underneath tree leaves. Their delicate, greenish…

The chemicals in nonstick pans and receipt paper were once believed to be invincible environmental contaminants

A big issue for publishing scientific research has been the cost. With the push for open access, new business models create new challenges for equitable access.

With rising fees for research journals, India is pressing ahead with a nation-wide subscription to allow more people to access science.

Are you ready for another lockdown? We may be headed that way. According to a recent study published in the journal Science Advances, increasing animal agriculture elevates the risk of zoonotic diseases, which are animal-borne and transmissible to humans, like COVID-19. So let’s do our part to thwart future pandemics…

Making it easier for scientists to study marijuana is a far cry from the liberalization that most Americans want.

The first drug that can slow the rate of decline in Alzheimer’s patients has been found. The experimental drug, called lecanemab, is an antibody that targets the toxic clumps of amyloid protein associated with the mind-robbing disease. While these results are cause for celebration, there are still significant questions about…

Two deaths linked to the drug may present a more complicated path to approval.